These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 18836149

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Biomarkers of systemic inflammation in stable and exacerbation phases of COPD.
    Karadag F, Karul AB, Cildag O, Yilmaz M, Ozcan H.
    Lung; 2008; 186(6):403-9. PubMed ID: 18807087
    [Abstract] [Full Text] [Related]

  • 24. Annual progression of endothelial dysfunction in patients with COPD.
    Clarenbach CF, Sievi NA, Kohler M.
    Respir Med; 2017 Nov; 132():15-20. PubMed ID: 29229089
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Endothelial dysfunction in chronic obstructive pulmonary disease.
    Moro L, Pedone C, Scarlata S, Malafarina V, Fimognari F, Antonelli-Incalzi R.
    Angiology; 2008 Nov; 59(3):357-64. PubMed ID: 18388072
    [Abstract] [Full Text] [Related]

  • 27. Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease.
    Thomsen M, Dahl M, Lange P, Vestbo J, Nordestgaard BG.
    Am J Respir Crit Care Med; 2012 Nov 15; 186(10):982-8. PubMed ID: 22983959
    [Abstract] [Full Text] [Related]

  • 28. Endogenous hydrogen sulfide in patients with COPD.
    Chen YH, Yao WZ, Geng B, Ding YL, Lu M, Zhao MW, Tang CS.
    Chest; 2005 Nov 15; 128(5):3205-11. PubMed ID: 16304263
    [Abstract] [Full Text] [Related]

  • 29. Hospitalized acute exacerbation of COPD impairs flow and nitroglycerin-mediated peripheral vascular dilation.
    Marchetti N, Ciccolella DE, Jacobs MR, Crookshank A, Gaughan JP, Kashem MA, Bove AA, Criner GJ.
    COPD; 2011 Apr 15; 8(2):60-5. PubMed ID: 21495833
    [Abstract] [Full Text] [Related]

  • 30. Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function.
    Waschki B, Watz H, Holz O, Magnussen H, Olejnicka B, Welte T, Rabe KF, Janciauskiene S.
    Int J Chron Obstruct Pulmon Dis; 2017 Apr 15; 12():981-987. PubMed ID: 28356730
    [Abstract] [Full Text] [Related]

  • 31. Local shear stress and brachial artery flow-mediated dilation: the Framingham Heart Study.
    Mitchell GF, Parise H, Vita JA, Larson MG, Warner E, Keaney JF, Keyes MJ, Levy D, Vasan RS, Benjamin EJ.
    Hypertension; 2004 Aug 15; 44(2):134-9. PubMed ID: 15249547
    [Abstract] [Full Text] [Related]

  • 32. Relationship between FEV1 and arterial stiffness in elderly people with chronic obstructive pulmonary disease.
    Costanzo L, Pedone C, Battistoni F, Chiurco D, Santangelo S, Antonelli-Incalzi R.
    Aging Clin Exp Res; 2017 Apr 15; 29(2):157-164. PubMed ID: 27000864
    [Abstract] [Full Text] [Related]

  • 33. Increased expression of interleukin-18 and its receptor in peripheral blood of patients with chronic obstructive pulmonary disease.
    Wang J, Liu X, Xie M, Xie J, Xiong W, Xu Y.
    COPD; 2012 Aug 15; 9(4):375-81. PubMed ID: 22489883
    [Abstract] [Full Text] [Related]

  • 34. [The influence of inflammatory process on the ventilatory impairment in patients with stable chronic obstructive pulmonary disease].
    Komnata K.
    Pneumonol Alergol Pol; 2010 Aug 15; 78(4):271-8. PubMed ID: 20665447
    [Abstract] [Full Text] [Related]

  • 35. Dysregulated adipokine metabolism in chronic obstructive pulmonary disease.
    Breyer MK, Rutten EP, Locantore NW, Watkins ML, Miller BE, Wouters EF, ECLIPSE Investigators (Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints).
    Eur J Clin Invest; 2012 Sep 15; 42(9):983-91. PubMed ID: 22703238
    [Abstract] [Full Text] [Related]

  • 36. Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery.
    Huang AL, Silver AE, Shvenke E, Schopfer DW, Jahangir E, Titas MA, Shpilman A, Menzoian JO, Watkins MT, Raffetto JD, Gibbons G, Woodson J, Shaw PM, Dhadly M, Eberhardt RT, Keaney JF, Gokce N, Vita JA.
    Arterioscler Thromb Vasc Biol; 2007 Oct 15; 27(10):2113-9. PubMed ID: 17717291
    [Abstract] [Full Text] [Related]

  • 37. Flow-mediated vasodilation and distensibility of the brachial artery in renal allograft recipients.
    Hausberg M, Kisters K, Kosch M, Rahn KH, Barenbrock M.
    Kidney Int; 1999 Mar 15; 55(3):1104-10. PubMed ID: 10027950
    [Abstract] [Full Text] [Related]

  • 38. Cardiovascular Studies in Patients with Chronic Obstructive Pulmonary Disease Due to Biomass Smoke or Tobacco.
    Golpe R, Sanjuán-López P, Martín-Robles I, González-Juanatey C, Pérez-de-Llano L, López-Campos JL.
    Lung; 2018 Apr 15; 196(2):195-200. PubMed ID: 29435736
    [Abstract] [Full Text] [Related]

  • 39. Interleukin-6 and interleukin-8 blood levels' poor association with the severity and clinical profile of ex-smokers with COPD.
    de Moraes MR, da Costa AC, Corrêa Kde S, Junqueira-Kipnis AP, Rabahi MF.
    Int J Chron Obstruct Pulmon Dis; 2014 Apr 15; 9():735-43. PubMed ID: 25114519
    [Abstract] [Full Text] [Related]

  • 40. Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation.
    Polatli M, Cakir A, Cildag O, Bolaman AZ, Yenisey C, Yenicerioglu Y.
    J Thromb Thrombolysis; 2008 Oct 15; 26(2):97-102. PubMed ID: 17622488
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.